Marketing
Area Network Marketing Manager(ANMM)は、担当地域において、地域特性に応じた骨粗鬆症診療ネットワークを構築・稼働・定着させる、実行力を核とするマーケティング職である。
基幹病院、クリニック、地域医師会をつなぎ、骨粗鬆症患者さんが適切なタイミングで評価され、重症度に応じた紹介、治療開始・継続・フォローアップに至る地域の患者導線を整備する。自治体との協業が地域の患者導線上の課題解決に有用な場合は、その機会と実装要件を特定し、V&AおよびMedical部門と連携して、コンプライアンスに沿った協業を推進する。Brand Planを地域で実行可能なquick winに翻訳し、地域ごとに最適な連携モデルを設計・推進する。
病院内におけるBone Care Pathway(BCP)の実装が進みつつある一方、地域に患者さんの受け皿が設計されていなければ、病院外来の負荷が過度に高まるおそれがある。ANMMは、病院で治療された患者さんを地域のクリニックにつなぐ、ならびにクリニックから病院またはDXA保有施設への適切な紹介が行われる仕組みを構築する。
経験
知識・スキル

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes.
For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads.
🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines
🔗Global Privacy Statement Directory: www.amgen.com/dp
Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.